Back to article
today.ucsd.edu

Semaglutide, a GLP-1 weight loss drug, slowed biological aging across multiple epigenetic clocks in a randomized, double-blind, placebo-controlled clinical tria... (opens in new tab)

Covers Pilot study of epigenetic aging and treatment response to semaglutide in the SLIM LIVER studyCovered by 3 sources See all sources covering this story including Información, Yahoo News

Feeds

✨ Discovered from this domain
UC San Diego Today today.ucsd.edu

Discover the latest news, research, people and ideas shaping UC San Diego and the world, from groundbreaking discoveries to campus life and community impact.

Keyboard Shortcuts

Navigation

Next / previous post
j/k
Open post
oorEnter
Preview post
v

Post Actions

Love post
a
Like post
l
Dislike post
d
Undo reaction
u
Save / unsave
s

Recommendations

Add interest / feed
Enter
Not interested
x

Go to

Home
gh
Interests
gi
Feeds
gf
Likes
gl
History
gy
Changelog
gc
Settings
gs
Discover
gb
Search
/

General

Show this help
?
Submit feedback
!
Close modal / unfocus
Esc

Press ? anytime to show this help